| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 8141 |
| 1 | METHOTREXATE | 7179 |
| 2 | ADALIMUMAB | 5998 |
| 3 | PREDNISONE | 5646 |
| 4 | ETANERCEPT | 4978 |
| 5 | LEFLUNOMIDE | 4624 |
| 6 | RITUXIMAB | 4525 |
| 7 | SULFASALAZINE | 4495 |
| 8 | INFLIXIMAB | 4483 |
| 9 | TOCILIZUMAB | 4325 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 2339 | 0.1857 |
| 1 | GOLD | 959 | 0.1651 |
| 2 | INFLIXIMAB-DYYB | 477 | 0.1384 |
| 3 | AZATHIOPRINE SODIUM | 321 | 0.1266 |
| 4 | DICLOFENAC POTASSIUM TABLETS | 1042 | 0.1202 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 699 | 0.1179 |
| 6 | CORTISONE ACETATE | 1187 | 0.0950 |
| 7 | PSEUDOEPHEDRINE HCL | 1039 | 0.0949 |
| 8 | DICLOFENAC POTASSIUM | 1042 | 0.0942 |
| 9 | DESOXIMETASONE | 1725 | 0.0895 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9646 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7842 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 7638 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 7295 |
| 4 | Aminosalicylate [EPC] | 4930 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 4912 |
| 6 | Antirheumatic Agent [EPC] | 4625 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 4401 |
| 8 | Vitamin C [EPC] | 4125 |
| 9 | Vitamin B12 [EPC] | 3912 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 868 | 1.2616 |
| 1 | Interleukin-17A Antagonist [EPC] | 2848 | 0.0764 |
| 2 | Provitamin D2 Compound [EPC] | 2051 | 0.0689 |
| 3 | Endoglycosidase [EPC] | 127 | 0.0685 |
| 4 | Aminosalicylate [EPC] | 4930 | 0.0489 |
| 5 | Antirheumatic Agent [EPC] | 4625 | 0.0437 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 649 | 0.0384 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 298 | 0.0342 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 4401 | 0.0317 |
| 9 | Antiseptic [EPC] | 135 | 0.0309 |